Alessia Filippone
Associate Professor of Pharmacology (SSD BIOS-11/A) at Unicamillus University, International Medical University of Rome.
From 2023 to 2025, she was a researcher (RTD-A) in Pharmacology at the Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences (ChiBioFaram) of the University of Messina, participating in the PNRR project “SAMOTHRACE – SiciliAn MicronanOTecH Research And Innovation Center – CUP J43C22000310006 (WP3 – Work Package Health – Advanced Micro-Nano Technologies and Devices for Health)”.
From 2022 to 2023, she was awarded a type B research grant for the research project “New therapeutic approaches to attenuate neuroinflammation” at the Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences (ChiBioFaram) of the University of Messina.
From 2021 to 2022, she was a research collaborator for EPITECH GROUP Spa, for the development of the Project “Development of therapeutic strategies based on N-Acylethanolamine for counteracting osteoarticular degeneration“.
In 2024, she obtained a Level II Professional Master’s degree in “Techniques of preparation of antiblastic drugs and evaluation of safety and efficacy of medical device”, with a thesis entitled “Drug delivery systems strategies for cancer treatment: overview of innovative approaches to counteract glioblastoma progression.”
In 2023, she obtained the National Scientific Qualification (ASN) for permanent Associate Professor positions at Italian universities: “National Scientific Qualification for the role of Associate University Professor in the Competition Sector BIOS-11/A (formerly 05/G1) – Pharmacology, clinical pharmacology and pharmacognosy.”
In 2020, she earned a PhD in “Applied Biology and Experimental Medicine” at the Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, with a thesis entitled “Modulation of inflammation, oxidative stress, and neuroinflammation by a short-chain fatty acid: protective effects of sodium propionate in in vitro and in vivo studies” for the realization of research projects based on the identification of new pharmacological targets to contrast peripheral and central nervous system inflammation through in vitro studies, performing various cell lines and in vivo models, and presenting these results at academic seminars and national and international conferences.
From 2019 to 2020, she was a Visiting Scientist at the Alzheimer’s Center at Temple University (ACT), Department of the Lewis Katz School of Medicine, Medical Education and Research Building (MERB), Philadelphia, PA (USA) for a project involving the analysis, execution, and interpretation of protein synthesis, transport, and evaluation of the pharmacodynamic and pharmacokinetic regulation of autophagic flux modulators in the perspective of Alzheimer’s disease using the murine neuroblastoma cell line expressing the human amyloid precursor peptide (APP) carrying the Swedish mutation (K670 – APPSwe cells).
In 2016 She earned a Master’s Degree in Biology (LM-6) from the Department of Chemical, Biological, Pharmaceutical, and Environmental Sciences (ChiBioFaram) at the University of Messina.
Her research focuses primarily on the study of the cellular mechanisms that regulate the progression of systemic and central nervous system inflammatory diseases, neurodegenerative diseases, and trauma, with particular attention to the identification of new pharmacological targets effective in modulating inflammation, cell death, and angiogenesis to restore physiological conditions such as the balance between oxidant/antioxidant species, the proper sorting, and the degradation of cellular proteins/organelles. Her research also focuses on the study of molecular mechanisms in tumor diseases such as glioblastoma and hepatocellular carcinoma, and the efficacy of pharmacological targets to counteract tumor progression.
Professor Alessia Filippone is the author of 73 publications (h-index 21) reviewed in international journals classified according to ISI Web of knowledge.
Professor Alessia Filippone is a member of both Italian and international scientific societies (Italian Society of Pharmacology, American Society for Pharmacology and Experimental Therapeutics) and has spoken at both national and international conferences.